iSpecimen Inc. (NASDAQ:ISPC), a Massachusetts-based biospecimen marketplace, experienced a remarkable 56.19% increase in its stock price during after-hours trading, reaching $0.20. This surge follows the company's announcement of a new shipping model that significantly reduces domestic transit times by 70-85%. The overhaul eliminates the previous centralized hub routing that added 7-14 days to delivery, allowing shipments to arrive in as little as 1-2 days. Additionally, this restructuring is expected to lower overall shipping costs. iSpecimen has also expanded its international sourcing partnerships across Europe, targeting rare specimens for urgent research needs. CEO Katie Field noted positive customer feedback regarding the careful sourcing and handling of research materials. Despite this positive news, the company reported a revenue of only $51,760 and an earnings per share of -0.74 in its latest quarterly report. Over the past year, ISPC stock has seen a dramatic decline of 90.84%, and it closed the regular session down 10.34% at $0.13, marking its 52-week low.